Health Enterprise Partners, a leading private equity firm focused on healthcare, announced that Roland Lyon has joined the firm as an Operating Partner. Lyon is an experienced healthcare executive and strategic advisor with more than 30 years of experience leading high-performing organizations across the healthcare sector. He has deep expertise in value-based care, operational performance improvement, and strategic growth initiatives.
Health Technology Insights: Nemluvio Shows Rapid Itch Relief and Sleep Benefits
Most recently, Lyon served as Senior Vice President for Strategy Implementation at Kaiser Permanente, where he was responsible for executing enterprise-wide strategic priorities and overseeing large-scale operational transformation projects. In this role, he played a key role in integrating Geisinger Health System following its acquisition by Risant Health.
Earlier in his career, Lyon held the position of President at Kaiser Foundation Health Plan of Colorado, the state’s largest integrated delivery system. In that role, he led a $4.2 billion organization supporting over 6,000 employees and providing care to hundreds of thousands of members.
Health Technology Insights: Form Health Offers Clear, Predictable GLP-1 Coverage for Employers
Dave Tamburri, Managing Partner at Health Enterprise Partners, praised Lyon’s appointment, highlighting his rare combination of payer and provider experience and noting the immediate impact he will have across HEP’s portfolio and strategic network. Tamburri also shared his personal excitement about working with Lyon, reflecting on their long-standing professional relationship.
As an Operating Partner, Lyon will collaborate with HEP’s investment professionals and portfolio company leadership teams to accelerate growth strategies, strengthen payer-provider alignment, and drive operational excellence. He will also support the firm’s investment strategy by assisting in identifying and evaluating new opportunities in healthcare technology and services that serve both payers and providers.
Roland Lyon expressed enthusiasm about joining HEP, emphasizing the firm’s history of partnering with innovators at the intersection of payers, providers, and patients. He said he looks forward to helping founders and management teams scale solutions that improve healthcare delivery and affordability for patients while advancing the performance of portfolio companies.
Health Technology Insights: FDA Approves Exdensur (Depemokimab) for Severe Asthma
To participate in our interviews, please write to our HealthTech Media Room at info@intentamplify.com
